Sanjivinica Medicines India Private Limited
Founded in 2020 and headquartered in Uttar Pradesh, India.
2020 | Ghaziabad, Uttar Pradesh (India) | Active
Sanjivinica Medicines India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
About Sanjivinica Medicines India
Sanjivinica Medicines India Private Limited (SMIPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 January 2020 (Five years and one month 26 days old ). Its registered office is in Ghaziabad, Uttar Pradesh, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Nilam Thakur and Thakur Rajnish serve as directors at the Company.
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24290UP2020PTC125216
- Company No.
125216
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jan 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Chemicals
Who are the key members and board of directors at Sanjivinica Medicines India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nilam Thakur  | Director | 01-Jan-2020 | Current |
| Thakur Rajnish | Director | 01-Jan-2020 | Current |
Financial Performance of Sanjivinica Medicines India.
Enhance accessibility to Sanjivinica Medicines India's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Sanjivinica Medicines India?
Unlock access to Sanjivinica Medicines India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Nilkanth Mobility Services India Private Limited
Nilam Thakur and Thakur Rajnish are mutual person
- Millennium Esotech Water Solutions India Private Limited
Nilam Thakur is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sanjivinica Medicines India?
Unlock and access historical data on people associated with Sanjivinica Medicines India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanjivinica Medicines India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanjivinica Medicines India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.